Novitas Capital
42
11M
28
1.62
5
0.33
15
- Stages of investment
- Areas of investment
Summary
In 1997 was created Novitas Capital, which is appeared as VC. The main office of represented VC is situated in the Wayne. The venture was found in North America in United States.
The fund was created by Michael G. Bolton. The overall number of key employees were 2.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Novitas Capital, startups are often financed by Ben Franklin Technology Partners of Northeastern Pennsylvania, Morgan Stanley, Technology Venture Partners. The meaningful sponsors for the fund in investment in the same round are Safeguard Scientifics, EuclidSR Partners, Battelle Ventures. In the next rounds fund is usually obtained by Ben Franklin Technology Partners of Northeastern Pennsylvania, Morgan Stanley, EuclidSR Partners.
The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2000. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2011. Comparing to the other companies, this Novitas Capital performs on 7 percentage points more the average number of lead investments.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Enterprise Software. Among the most popular portfolio startups of the fund, we may highlight TetraLogic Pharmaceuticals, E-Duction, Logical Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 42
- Lead investments
- 5
- Exits
- 15
- Rounds per year
- 1.62
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (12)
- Health Care (8)
- Software (6)
- Internet (6)
- Medical (5) Show 55 more
- Investments by region
- United States (42)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 20M
- Group Appearance index
- 0.95
- Avg. company exit year
- 11
- Avg. multiplicator
- 1.28
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cavendish Kinetics | 01 May 2006 | Software, Semiconductor, Consumer Electronics, Wireless | Early Stage Venture | 15M | United States, California, San Jose |
| MedCases | 12 May 2000 | Internet, Education, Medical | Early Stage Venture | 3M | United States, New Jersey |
| Renal Solutions | 08 Mar 2005 | Health Care, Medical Device, Medical | Early Stage Venture | 16M | United States, Pennsylvania |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.